Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.75 |
| ▸ | MAPT | P10636 | 4/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | CA12 | O43570 | 1/20 | 0.55 |
| ▸ | CA1 | P00915 | 1/20 | 0.55 |
| ▸ | CA2 | P00918 | 1/20 | 0.55 |
| ▸ | CA7 | P43166 | 1/20 | 0.55 |
| ▸ | CA9 | Q16790 | 1/20 | 0.55 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 3/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | HTT | P42858 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 3/20 | 0.46 |
| ▸ | RAB9A | P51151 | 3/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7733701 | 0.86 | L3MBTL1 (1.00) | L3MBTL1MAPTALDH1A1CA12CA1 | |
| SCHEMBL5201283 | 0.85 | L3MBTL1 (0.54) | L3MBTL1MAPTALDH1A1CA12CA1 | |
| SCHEMBL4573229 | 0.83 | L3MBTL1 (0.52) | L3MBTL1MAPTALDH1A1CA12CA1 | |
| SCHEMBL202154 | 0.81 | CA12 (0.53) | L3MBTL1MAPTCA12CA1CA2 | |
| SCHEMBL83110 | 0.80 | L3MBTL1 (0.78) | L3MBTL1MAPTALDH1A1CA12CA1 | |
| SCHEMBL4628897 | 0.79 | L3MBTL1 (0.63) | L3MBTL1MAPTALDH1A1CA12CA1 | |
| SCHEMBL2076593 | 0.79 | L3MBTL1 (0.57) | L3MBTL1MAPTALDH1A1CA12CA1 | |
| SCHEMBL5523100 | 0.79 | L3MBTL1 (0.47) | L3MBTL1MAPTALDH1A1CA12CA1 | |
| SCHEMBL1422823 | 0.78 | L3MBTL1 (0.83) | L3MBTL1MAPTALDH1A1CA12CA1 | |
| SCHEMBL18033762 | 0.78 | L3MBTL1 (0.83) | L3MBTL1MAPTALDH1A1CA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 164 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3740493-B1 | INHIBTEURS DE L'INDOLEAMINE 2,3-DIOXYGÉNASE ET/OU DU TRYPTOPHANE DIOXYGÉNASE | IDORSIA PHARMACEUTICALS LTD (CH) | 2021-12-01 | — | — | EP | claimed |
| US-20200405696-A1 | INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND/OR TRYPTOPHAN 2,3-DIOXYGENASE | IDORSIA PHARMACEUTICALS LTD (CH) | 2020-12-31 | — | — | US | claimed |
| US-20120165334-A1 | Indole/Benzimidazole Compounds as mTOR Kinase Inhibitors | AMGEN INC. (US) | 2012-06-28 | — | — | US | claimed |
| EP-2398791-A1 | INDOLE/BENZIMIDAZOLE COMPOUNDS AS mTOR KINASE INHIBITORS | Amgen, Inc (US) | 2011-12-28 | — | — | EP | claimed |
| US-20110294853-A1 | Bis Aromatic Compounds for Use in the Treatment of Inflammation | BIOLIPOX AB (SE) | 2011-12-01 | — | — | US | claimed |
| WO-2010096314-A1 | INDOLE/BENZIMIDAZOLE COMPOUNDS AS mTOR KINASE INHIBITORS | AMGEN INC. (US) | 2010-08-26 | — | — | WO | claimed |
| WO-2010029300-A1 | BIS AROMATIC COMPOUNDS FOR USE IN THE TREATMENT OF INFLAMMATION | BIOLIPOX AB (SE) | 2010-03-18 | — | — | WO | claimed |
| CN-100562545-C | Ink for inkjet recording and inkjet recording method | FUJI PHOTO FILM CO LTD (JP) | 2009-11-25 | — | — | CN | claimed |
| CN-100381513-C | Ink set for inkjet recording and inkjet recording method | FUJI PHOTO FILM CO LTD (JP) | 2008-04-16 | — | — | CN | claimed |
| CN-100371401-C | Ink composition and method of ink-jet recording | FUJI PHOTO FILM CO LTD (JP) | 2008-02-27 | — | — | CN | claimed |
| CN-100346968-C | Ink-jet recording ink and method of ink-jet recording | FUJI PHOTO FILM CO LTD (JP) | 2007-11-07 | — | — | CN | claimed |
| US-20050192292-A1 | Pyrrolidone carboxamides | ACTELION PHARMACEUTICALS AG (CH) | 2005-09-01 | — | — | US | claimed |
| EP-1463724-A1 | PYRROLIDONE CARBOXAMIDES | Actelion Pharmaceuticals Ltd. (CH) | 2004-10-06 | — | — | EP | claimed |
| WO-2003059905-A1 | PYRROLIDONE CARBOXAMIDES | ACTELION PHARMACEUTICALS LTD (CH) | 2003-07-24 | — | — | WO | claimed |
| EP-3740493-B1 | INHIBTEURS DE L'INDOLEAMINE 2,3-DIOXYGÉNASE ET/OU DU TRYPTOPHANE DIOXYGÉNASE | IDORSIA PHARMACEUTICALS LTD (CH) | 2021-12-01 | — | — | EP | disclosed |
| US-10894898-B2 | Water-based ink for ink-jet recording and ink container | BROTHER KOGYO KABUSHIKI KAISHA (JP) | 2021-01-19 | — | — | US | disclosed |
| US-20210009575-A1 | HYDROXYISOXAZOLINES AND DERIVATIVES THEREOF | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2021-01-14 | — | — | US | disclosed |
| EP-0360289-A2 | Positive working silver halide color photographic material | FUJI PHOTO FILM CO., LTD. (JP) | 1990-03-28 | — | — | EP | disclosed |
| US-4692187-A | HERBICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1987-09-08 | — | — | US | disclosed |
| EP-0192111-A1 | Iso-ureas, processes for their production and their use as herbicides | BASF Aktiengesellschaft (DE) | 1986-08-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210009575-A1 | HYDROXYISOXAZOLINES AND DERIVATIVES THEREOF | CYP4X1, CYP3A7, CYP4Z1 | L3MBTL1 4074/4885MAPT 4072/4885ALDH1A1 1143/4885 |
| US-20120165334-A1 | Indole/Benzimidazole Compounds as mTOR Kinase Inhibitors | MTOR, PIKFYVE, RICTOR | L3MBTL1 2849/4885MAPT 2000/4885ALDH1A1 4371/4885 |
| US-20050192292-A1 | Pyrrolidone carboxamides | NPY1R, NPY5R, NPY2R | L3MBTL1 3047/4885MAPT 4395/4885ALDH1A1 3034/4885 |
| US-20200405696-A1 | INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND/OR TRYPTOPHAN 2,3-DIOXYGENASE | IDO2, TDO2, IDO1 | L3MBTL1 3213/4885MAPT 3139/4885ALDH1A1 631/4885 |
| US-20110294853-A1 | Bis Aromatic Compounds for Use in the Treatment of Inflammation | LTC4S, LTB4R2, LTB4R | L3MBTL1 569/4885MAPT 3484/4885ALDH1A1 663/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.